Think Rheumatoid Arthritis: Causes, Consequences, and Management - European Medical Journal

This site is intended for healthcare professionals

Think Rheumatoid Arthritis: Causes, Consequences, and Management

Rheumatology
Download PDF
Chairpeople:
Josef Smolen , 1 Costantino Pitzalis 2
Speakers:
Josef Smolen , 1 Costantino Pitzalis , 2 Simon Jones , 3 Frank McKenna 4
Acknowledgements:

Writing assistance was provided by Kabira Alieva of ApotheCom.

Keywords:
EULAR, European League Against Rheumatism
Citation:
EMJ Rheumatol. ;3[1]:66-73. DOI/10.33590/emjrheumatol/10314552. https://doi.org/10.33590/emjrheumatol/10314552.
Support:

The symposium was sponsored by Janssen Pharmaceutica NV. Authors received honoraria for preparation and delivery of their presentations. The views and opinions expressed are those of the authors and not necessarily of Janssen Pharmaceutica NV.

Each article is made available under the terms of the Creative Commons Attribution-Non Commercial 4.0 License.

Meeting Summary

Prof Josef Smolen opened the symposium and briefly described the aims of the meeting. Co-host Prof Constantino Pitzalis first discussed the pathophysiology of rheumatoid arthritis (RA), identifying the pro-inflammatory cytokines involved and explaining why specific drugs only work in certain conditions. Prof Simon Jones followed with a discussion on comorbidities and adverse events associated with interleukin (IL)-6 intervention in rheumatic disease. Dr Frank McKenna presented on the psychological impact of RA, including mood changes and development of depressive disorders, and Prof Smolen described the upcoming therapeutic approaches for the condition while also comparing and contrasting existing treatment options. The symposium concluded with a question and answer session.

Please view the full content in the PDF above. 

Rate this content's potential impact on patient outcomes

Average rating / 5. Vote count:

No votes so far! Be the first to rate this content.